🕵️ MINK Therapeutics, Inc. ($INKT)
SEC insider & ownership activity, last 12 months · CIK 1840229 · every row links its SEC filing
Over the last 12 months insiders sold $47K with no open-market buying against it. Ryan Barbara sold $47K (Feb–Jun). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $47K (8 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Ryan Barbara | 0 | – | 8 | $47K | Jun 4, 2026 |
5%+ holders
No current 5%+ beneficial-ownership positions on file.
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Agenus Inc. | $12.6M | Aug 29, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Earnings (2.02) | Mar 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 31, 2026 | filing ↗ |
| Other events (8.01) | Mar 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Dec 29, 2025 | filing ↗ |
| Earnings (2.02) | Nov 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 14, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 23, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 23, 2025 | filing ↗ |
| Earnings (2.02) | Aug 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2025 | filing ↗ |